View Item 

Show simple item record

Comparative analysis of portal hepatic infiltrating leucocytes in acute drug‐induced liver injury, idiopathic autoimmune and viral hepatitis

dc.contributor.authorFoureau, D. M.en_US
dc.contributor.authorWalling, T. L.en_US
dc.contributor.authorMaddukuri, V.en_US
dc.contributor.authorAnderson, W.en_US
dc.contributor.authorCulbreath, K.en_US
dc.contributor.authorKleiner, D. E.en_US
dc.contributor.authorAhrens, W. A.en_US
dc.contributor.authorJacobs, C.en_US
dc.contributor.authorWatkins, P. B.en_US
dc.contributor.authorFontana, R. J.en_US
dc.contributor.authorChalasani, N.en_US
dc.contributor.authorTalwalkar, J.en_US
dc.contributor.authorLee, W. M.en_US
dc.contributor.authorStolz, A.en_US
dc.contributor.authorSerrano, J.en_US
dc.contributor.authorBonkovsky, H. L.en_US
dc.date.accessioned2015-04-02T15:12:26Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-04en_US
dc.identifier.citationFoureau, D. M.; Walling, T. L.; Maddukuri, V.; Anderson, W.; Culbreath, K.; Kleiner, D. E.; Ahrens, W. A.; Jacobs, C.; Watkins, P. B.; Fontana, R. J.; Chalasani, N.; Talwalkar, J.; Lee, W. M.; Stolz, A.; Serrano, J.; Bonkovsky, H. L. (2015). "Comparative analysis of portal hepatic infiltrating leucocytes in acute drug‐induced liver injury, idiopathic autoimmune and viral hepatitis." Clinical & Experimental Immunology 180(1): 40-51.en_US
dc.identifier.issn0009-9104en_US
dc.identifier.issn1365-2249en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110851
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherSaunders‐Elsevieren_US
dc.subject.otherautoimmunityen_US
dc.subject.otherviral hepatitisen_US
dc.subject.otherdrug‐induced liver injuryen_US
dc.subject.otherinflammationen_US
dc.titleComparative analysis of portal hepatic infiltrating leucocytes in acute drug‐induced liver injury, idiopathic autoimmune and viral hepatitisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110851/1/cei12558.pdf
dc.identifier.doi10.1111/cei.12558en_US
dc.identifier.sourceClinical & Experimental Immunologyen_US
dc.identifier.citedreferenceWashington MK. Autoimmune liver disease: overlap and outliers. Mod Pathol 2007; 20 ( Suppl. 1 ): S15 – 30.en_US
dc.identifier.citedreferenceDoherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174: 5 – 20.en_US
dc.identifier.citedreferenceKurachi K, Suzuki S, Sakaguchi T et al. Kupffer cells modulate splenic interleukin‐10 production in endotoxin‐induced liver injury after partial hepatectomy. J Hepatol 2003; 38: 193 – 199.en_US
dc.identifier.citedreferenceJost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol 2013; 31: 163 – 194.en_US
dc.identifier.citedreferenceKelly DA. Acute liver failure. Indian J Pediatr 1999; 66: S104 – 109.en_US
dc.identifier.citedreferenceWasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis – United States, 2006. MMWR Surveill Summ 2008; 57: 1 – 24.en_US
dc.identifier.citedreferenceMcFarlane IG, Heneghan MA. Autoimmunity and the female liver. Hepatol Res 2004; 28: 171 – 176.en_US
dc.identifier.citedreferenceBahjat KS, Prell RA, Allen HE et al. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. J Immunol 2007; 179: 7376 – 7384.en_US
dc.identifier.citedreferenceNavarro VJ, Barnhart H, Bonkovsky HL et al. Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network. Hepatology 2014; 60: 1399 – 1408.en_US
dc.identifier.citedreferenceChitturi S, Farell GC. Adverse effects of hormones and hormone antagonists on the liver. In: Kaplowitz N, Deleve LD, eds. Drug‐induced liver disease, 2nd edn. Amsterdam: Elsevier, 2007: 702 – 722.en_US
dc.identifier.citedreferenceMichael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999; 30: 186 – 195.en_US
dc.identifier.citedreferenceHolt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen‐induced liver injury. J Leukoc Biol 2008; 84: 1410 – 1421.en_US
dc.identifier.citedreferenceSuzuki A, Brunt EM, Kleiner DE et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug‐induced liver injury. Hepatology 2011; 54: 931 – 939.en_US
dc.identifier.citedreferenceRubio CA. Detecting plasma cell precursors in autoimmune hepatitis. In Vivo 2012; 26: 319 – 321.en_US
dc.identifier.citedreferenceVogel A, Manns MP, Strassburg CP. Autoimmunity and viruses. Clin Liver Dis 2002; 6: 739 – 753.en_US
dc.identifier.citedreferenceKaplowitz N. Drug‐induced liver injury. Clin Infect Dis 2004; 38 ( Suppl. 2 ): S44 – 48.en_US
dc.identifier.citedreferenceKleiner DE. The pathology of drug‐induced liver injury. Semin Liver Dis 2009; 29: 364 – 372.en_US
dc.identifier.citedreferenceKelly BD, Heneghan MA, Bennani F, Connolly CE, O'Gorman TA. Nitrofurantoin‐induced hepatotoxicity mediated by CD8+ T cells. Am J Gastroenterol 1998; 93: 819 – 821.en_US
dc.identifier.citedreferenceWinwood PJ, Arthur MJ. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993; 13: 50 – 59.en_US
dc.identifier.citedreferenceKleiner DE, Chalasani NP, Lee WM et al. Hepatic histological findings in suspected drug‐induced liver injury: systematic evaluation and clinical associations. Hepatology 2014; 59: 661 – 670.en_US
dc.identifier.citedreferenceIshak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696 – 699.en_US
dc.identifier.citedreferenceFontana RJ, Watkins PB, Bonkovsky HL et al. Drug‐Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32: 55 – 68.en_US
dc.identifier.citedreferenceChalasani N, Fontana RJ, Bonkovsky HL et al. Causes, clinical features, and outcomes from a prospective study of drug‐induced liver injury in the United States. Gastroenterology 2008; 135: 1924 – 1934, 34 e1–4.en_US
dc.identifier.citedreferenceBonkovsky HL, Shedlofsky SI, Jones DP, Russo M. Drug‐induced liver injury. Chapter 25. In: Boyer TD, Manns MP, Sanyal A, eds. Zakim and Boyer's hepatology – a textbook of liver disease, 6th edn. Philadelphia: Saunders‐Elsevier, 2012: 417 – 461.en_US
dc.identifier.citedreferencedeLemos AS, Foureau DM, Jacobs C, Ahrens W, Russo MW, Bonkovsky HL. Drug‐induced liver injury with autoimmune features. Semin Liver Dis 2014; 34: 194 – 204.en_US
dc.identifier.citedreferenceRockey DC, Seeff LB, Rochon J et al. Causality assessment in drug‐induced liver injury using a structured expert opinion process: comparison to the Roussel–Uclaf causality assessment method. Hepatology 2010; 51: 2117 – 2126.en_US
dc.identifier.citedreferenceNovobrantseva TI, Majeau GR, Amatucci A et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115: 3072 – 3082.en_US
dc.identifier.citedreferenceCheever AW, Williams ME, Wynn TA et al. Anti‐IL‐4 treatment of Schistosoma mansoni ‐infected mice inhibits development of T cells and non‐B, non‐T cells expressing Th2 cytokines while decreasing egg‐induced hepatic fibrosis. J Immunol 1994; 153: 753 – 759.en_US
dc.identifier.citedreferenceFontana RJ, Seeff LB, Andrade RJ et al. Standardization of nomenclature and causality assessment in drug‐induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52: 730 – 742.en_US
dc.identifier.citedreferenceJaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166 – 176.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cei12558.pdf
Size:
455.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.